Artificial Corneal Implants

Global Artificial Corneal Implants Market to Reach US$120.9 Million by 2030

The global market for Artificial Corneal Implants estimated at US$82.8 Million in the year 2024, is expected to reach US$120.9 Million by 2030, growing at a CAGR of 6.5% over the analysis period 2024-2030. Hard Keratoprosthesis, one of the segments analyzed in the report, is expected to record a 5.7% CAGR and reach US$65.7 Million by the end of the analysis period. Growth in the Soft Keratoprosthesis segment is estimated at 7.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$21.8 Million While China is Forecast to Grow at 6.4% CAGR

The Artificial Corneal Implants market in the U.S. is estimated at US$21.8 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$19.5 Million by the year 2030 trailing a CAGR of 6.4% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 5.9% and 5.6% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.3% CAGR.

Global Artificial Corneal Implants Market – Key Trends & Drivers Summarized

How Are Artificial Corneal Implants Addressing Vision Loss?
Artificial corneal implants are transforming the treatment landscape for corneal blindness and damage, providing an alternative for patients who cannot undergo traditional corneal transplants. Conditions such as keratoconus, corneal scarring, and dystrophies have made these implants a critical solution for restoring vision. With advancements in biocompatible materials and surgical techniques, these implants offer improved integration and reduced risk of rejection. The rising prevalence of corneal diseases, coupled with a shortage of donor corneas globally, has fueled demand for artificial implants as a reliable and accessible option.

What Role Do Technological Advancements Play in Enhancing Outcomes?
The artificial corneal implant market is witnessing rapid innovation, with a focus on improving durability, biocompatibility, and surgical ease. Advanced materials such as hydrogels and nanocomposites mimic the natural cornea’s properties, ensuring better optical clarity and reduced complications. 3D printing technologies are being utilized to create patient-specific implants, enhancing precision and outcomes. Minimally invasive surgical techniques have also emerged, reducing recovery times and increasing accessibility for patients in low-resource settings. These technological strides have positioned artificial corneal implants as a cornerstone of modern ophthalmology.

Why Is Accessibility a Key Focus for Market Growth?
Accessibility is a major factor driving the adoption of artificial corneal implants, especially in developing countries where the burden of corneal blindness is highest. Non-governmental organizations and healthcare systems are investing in awareness campaigns and subsidized treatments to bridge the accessibility gap. Additionally, the emergence of cost-effective implant options has expanded availability in underserved regions. Partnerships between manufacturers, governments, and healthcare providers are ensuring that these life-changing treatments reach the people who need them most.

What Drives the Growth of the Artificial Corneal Implants Market?
The growth in the artificial corneal implants market is driven by an increasing prevalence of corneal diseases and a global shortage of donor corneas. Advancements in materials science and 3D printing have enabled the production of highly durable and patient-specific implants, improving surgical outcomes. The rise in geriatric populations and the associated risk of vision loss further boosts demand. Consumer awareness and government initiatives promoting eye health are expanding the market’s reach. Moreover, technological breakthroughs in minimally invasive procedures are making corneal implants more accessible and affordable, ensuring sustained growth in this sector.

SCOPE OF STUDY:

The report analyzes the Artificial Corneal Implants market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Transplant Type (Hard Keratoprosthesis, Soft Keratoprosthesis); Implant Type (Synthetic Implant, Biosynthetic Implant); Indication (Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid (OCP) Indication, Corneal Stromal Dystrophies Indication, Stevens-Johnson Syndrome (SJS) Indication, Other Indications); End-Use (Hospitals End-Use, Ophthalmic Centers End-Use, Ambulatory Surgical Centers End-Use)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 44 Featured) -
  • AJL Ophthalmic S.A.
  • Aurolab
  • Beijing mikpro medical device Co., Ltd.
  • CorneaGen
  • Corneat Vision Ltd.
  • DIOPTEX GmbH
  • EyeYon Medical Ltd.
  • FCI Ophthalmics, Inc.
  • Keramed Inc.
  • LinkoCare Life Sciences AB
  • Mediphacos
  • San Diego Eye Bank

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.


I. METHODOLOGY
II. EXECUTIVE SUMMARY
1. MARKET OVERVIEW
Influencer Market Insights
Tariff Impact on Global Supply Chain Patterns
Artificial Corneal Implants – Global Key Competitors Percentage Market Share in 2025 (E)
Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
2. FOCUS ON SELECT PLAYERS
3. MARKET TRENDS & DRIVERS
Rising Prevalence of Corneal Blindness and Vision Disorders Driving Demand
Increasing Success Rates of Synthetic and Bioengineered Corneal Implants
Advancements in Stem Cell Therapy for Corneal Regeneration Supporting Growth
Growing Adoption of 3D Bioprinting Technology in Artificial Corneal Implants
Expansion of Minimally Invasive Corneal Implantation Techniques
Increasing Collaborations Between Ophthalmic Research Institutes and Manufacturers
Rising Geriatric Population Driving Demand for Vision Restoration Solutions
Advancements in Biocompatible and Long-Lasting Implant Materials
Expanding Access to Corneal Transplant Alternatives in Developing Countries
Growing Use of AI and Robotics in Corneal Implantation Surgeries
Surge in FDA and Regulatory Approvals for Next-Generation Implants
Rising Private and Government Investments in Ophthalmic Healthcare
4. GLOBAL MARKET PERSPECTIVE
TABLE 1: World Artificial Corneal Implants Market Analysis of Annual Sales in US$ for Years 2015 through 2030
TABLE 2: World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 3: World 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2025 & 2030
TABLE 4: World Recent Past, Current & Future Analysis for Hard Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 5: World 6-Year Perspective for Hard Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 6: World Recent Past, Current & Future Analysis for Soft Keratoprosthesis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 7: World 6-Year Perspective for Soft Keratoprosthesis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 8: World Recent Past, Current & Future Analysis for Other Indications by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 9: World 6-Year Perspective for Other Indications by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 10: World Recent Past, Current & Future Analysis for Keratoconus Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 11: World 6-Year Perspective for Keratoconus Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 12: World Recent Past, Current & Future Analysis for Ocular Burns Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 13: World 6-Year Perspective for Ocular Burns Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 14: World Recent Past, Current & Future Analysis for Ocular Cicatricial Pemphigoid Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 15: World 6-Year Perspective for Ocular Cicatricial Pemphigoid Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 16: World Recent Past, Current & Future Analysis for Corneal Stromal Dystrophies Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 17: World 6-Year Perspective for Corneal Stromal Dystrophies Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 18: World Recent Past, Current & Future Analysis for Stevens-Johnson Syndrome Indication by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 19: World 6-Year Perspective for Stevens-Johnson Syndrome Indication by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 20: World Recent Past, Current & Future Analysis for Hospitals End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 21: World 6-Year Perspective for Hospitals End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 22: World Recent Past, Current & Future Analysis for Ophthalmic Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 23: World 6-Year Perspective for Ophthalmic Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 24: World Recent Past, Current & Future Analysis for Ambulatory Surgical Centers End-Use by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 25: World 6-Year Perspective for Ambulatory Surgical Centers End-Use by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 26: World Recent Past, Current & Future Analysis for Synthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 27: World 6-Year Perspective for Synthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
TABLE 28: World Recent Past, Current & Future Analysis for Biosynthetic Implant by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 29: World 6-Year Perspective for Biosynthetic Implant by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2025 & 2030
III. MARKET ANALYSIS
UNITED STATES
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
TABLE 30: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 31: USA 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 32: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 33: USA 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 34: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 35: USA 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 36: USA Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 37: USA 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
CANADA
TABLE 38: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 39: Canada 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 40: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 41: Canada 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 42: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 43: Canada 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 44: Canada Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 45: Canada 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
JAPAN
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
TABLE 46: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 47: Japan 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 48: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 49: Japan 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 50: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 51: Japan 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 52: Japan Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 53: Japan 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
CHINA
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
TABLE 54: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 55: China 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 56: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 57: China 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 58: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 59: China 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 60: China Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 61: China 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
EUROPE
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
TABLE 62: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ for Years 2024 through 2030 and % CAGR
TABLE 63: Europe 6-Year Perspective for Artificial Corneal Implants by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2025 & 2030
TABLE 64: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 65: Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 66: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 67: Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 68: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 69: Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 70: Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 71: Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
FRANCE
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
TABLE 72: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 73: France 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 74: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 75: France 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 76: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 77: France 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 78: France Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 79: France 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
GERMANY
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
TABLE 80: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 81: Germany 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 82: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 83: Germany 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 84: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 85: Germany 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 86: Germany Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 87: Germany 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
ITALY
TABLE 88: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 89: Italy 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 90: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 91: Italy 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 92: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 93: Italy 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 94: Italy Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 95: Italy 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
UNITED KINGDOM
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
TABLE 96: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 97: UK 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 98: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 99: UK 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 100: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 101: UK 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 102: UK Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 103: UK 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
REST OF EUROPE
TABLE 104: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 105: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 106: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 107: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 108: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 109: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 110: Rest of Europe Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 111: Rest of Europe 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
ASIA-PACIFIC
Artificial Corneal Implants Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
TABLE 112: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 113: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 114: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 115: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 116: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 117: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 118: Asia-Pacific Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 119: Asia-Pacific 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
REST OF WORLD
TABLE 120: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Transplant Type - Hard Keratoprosthesis and Soft Keratoprosthesis - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 121: Rest of World 6-Year Perspective for Artificial Corneal Implants by Transplant Type - Percentage Breakdown of Value Sales for Hard Keratoprosthesis and Soft Keratoprosthesis for the Years 2025 & 2030
TABLE 122: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Indication - Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 123: Rest of World 6-Year Perspective for Artificial Corneal Implants by Indication - Percentage Breakdown of Value Sales for Other Indications, Keratoconus Indication, Ocular Burns Indication, Ocular Cicatricial Pemphigoid Indication, Corneal Stromal Dystrophies Indication and Stevens-Johnson Syndrome Indication for the Years 2025 & 2030
TABLE 124: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by End-Use - Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 125: Rest of World 6-Year Perspective for Artificial Corneal Implants by End-Use - Percentage Breakdown of Value Sales for Hospitals End-Use, Ophthalmic Centers End-Use and Ambulatory Surgical Centers End-Use for the Years 2025 & 2030
TABLE 126: Rest of World Recent Past, Current & Future Analysis for Artificial Corneal Implants by Implant Type - Synthetic Implant and Biosynthetic Implant - Independent Analysis of Annual Sales in US$ for the Years 2024 through 2030 and % CAGR
TABLE 127: Rest of World 6-Year Perspective for Artificial Corneal Implants by Implant Type - Percentage Breakdown of Value Sales for Synthetic Implant and Biosynthetic Implant for the Years 2025 & 2030
IV. COMPETITION

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings